Serum Uric Acid Level Associated With Metabolic Syndrome
|
By LabMedica International staff writers Posted on 27 Sep 2015 |
|
Image: Spiked rods of uric acid crystals from a synovial fluid sample photographed under a microscope with polarized light (Photo courtesy of Bobjgalindo).
Metabolic syndrome (MetS) is defined by a cluster of risk factors, including obesity, dyslipidemia, hypertension, and insulin resistance, and when occurring together, they increase the risk of developing cardiovascular disease (CVD) and diabetes.
Serum uric acid is a final enzymatic product of purine metabolism in humans, and it is suggested that hyperuricemia is associated with MetS, and they may have common pathophysiology and in addition to MetS, elevated concentrations of uric acid are associated with a variety of cardiovascular conditions.
Scientists at Tehran University of Medical Sciences, (Iran) carried out a case-control study comprised 101 non-smoking individuals, 41 in the MetS group and 60 in the non-MetS group. Blood pressure, fasting plasma glucose, insulin, lipid profiles, uric acid, and anthropometric measures were determined, and body composition was assessed by using bioelectrical impedance analysis (BIA). Homeostasis Model Assessment (HOMA) was used for the assessment of insulin resistance.
Total cholesterol (TC) and TG were determined enzymatically using Parsazmun kits (Tehran, Iran). High density lipoprotein cholesterol (HDL-C) was measured similarly after precipitation with magnesium phosphotungstate. LDL-cholesterol was calculated using Friedewald’s formula. Fasting plasma glucose (FPG was measured using the glucose oxidase method, and immunoreactive insulin (IRI) was measured by radioimmunoassay.
After adjustment for confounding factors, serum uric acid was statistically significantly higher in MetS group at 5.70 ± 1.62 mg/dL than in non-MetS group 4.97 ± 1.30 mg/dL. Subjects in the MetS group had higher anthropometric and blood pressure measurements, body mass index (BMI), lean body mass (LBM), body fat mass (BFM), FPG, insulin, HOMA index, TG, TC, LDL, and lower HDL levels than the subjects in the non-MetS group.
The authors concluded that serum uric acid had independent association with MetS components, and increased the risk of MetS by nearly two-fold. The findings propose that uric acid can be considered as a component of MetS. The study was published on September 15, 2015, in the Journal of Diabetes & Metabolic Disorders.
Related Links:
Tehran University of Medical Sciences
Parsazmun
Serum uric acid is a final enzymatic product of purine metabolism in humans, and it is suggested that hyperuricemia is associated with MetS, and they may have common pathophysiology and in addition to MetS, elevated concentrations of uric acid are associated with a variety of cardiovascular conditions.
Scientists at Tehran University of Medical Sciences, (Iran) carried out a case-control study comprised 101 non-smoking individuals, 41 in the MetS group and 60 in the non-MetS group. Blood pressure, fasting plasma glucose, insulin, lipid profiles, uric acid, and anthropometric measures were determined, and body composition was assessed by using bioelectrical impedance analysis (BIA). Homeostasis Model Assessment (HOMA) was used for the assessment of insulin resistance.
Total cholesterol (TC) and TG were determined enzymatically using Parsazmun kits (Tehran, Iran). High density lipoprotein cholesterol (HDL-C) was measured similarly after precipitation with magnesium phosphotungstate. LDL-cholesterol was calculated using Friedewald’s formula. Fasting plasma glucose (FPG was measured using the glucose oxidase method, and immunoreactive insulin (IRI) was measured by radioimmunoassay.
After adjustment for confounding factors, serum uric acid was statistically significantly higher in MetS group at 5.70 ± 1.62 mg/dL than in non-MetS group 4.97 ± 1.30 mg/dL. Subjects in the MetS group had higher anthropometric and blood pressure measurements, body mass index (BMI), lean body mass (LBM), body fat mass (BFM), FPG, insulin, HOMA index, TG, TC, LDL, and lower HDL levels than the subjects in the non-MetS group.
The authors concluded that serum uric acid had independent association with MetS components, and increased the risk of MetS by nearly two-fold. The findings propose that uric acid can be considered as a component of MetS. The study was published on September 15, 2015, in the Journal of Diabetes & Metabolic Disorders.
Related Links:
Tehran University of Medical Sciences
Parsazmun
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1
Latest Clinical Chem. News
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
- New Blood Testing Method Detects Potent Opioids in Under Three Minutes
- Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step
- Pain-Free, Low-Cost, Sensitive, Radiation-Free Device Detects Breast Cancer in Urine
- Spit Test Detects Breast Cancer in Five Seconds
- Electrochemical Sensors with Next-Generation Coating Advances Precision Diagnostics at POC
- First-Of-Its-Kind Handheld Device Accurately Detects Fentanyl in Urine within Seconds
- New Fluorescent Sensor Array Lights up Alzheimer’s-Related Proteins for Earlier Detection
- Automated Mass Spectrometry-Based Clinical Analyzer Could Transform Lab Testing
- Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses
- Non-Invasive Sensor Monitors Changes in Saliva Compositions to Rapidly Diagnose Diabetes
- Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia
- Urine Test for Monitoring Changes in Kidney Health Markers Can Predict New-Onset Heart Failure
- AACC Releases Comprehensive Diabetes Testing Guidelines
Channels
Molecular Diagnostics
view channel
World’s First One-Minute Hepatitis C Antibody Test Facilitates Quick Triage
Rapid and accurate testing is crucial in the fight against Hepatitis C. Hepatitis C blood testing determines whether someone has been infected with the Hepatitis C virus. Having regular access to testing... Read more
Game-Changing Blood Test for Stroke Detection Could Bring Life-Saving Care to Patients
Stroke is the primary cause of disability globally and ranks as the second leading cause of death. However, timely early intervention can prevent severe outcomes. Most strokes are ischemic, resulting from... Read more
 (1)_1.jpg "Image: Ultrasound image of micro-histotripsy liberation of biomarkers in a tumor (Photo courtesy of Joy Wang and Pradyumna Kedarisetti)"){kind=small}
Hematology
view channel
Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more
First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
Arboviruses represent an emerging global health threat, exacerbated by climate change and increased international travel that is facilitating their spread across new regions. Chikungunya, dengue, West... Read more
POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read moreImmunology
view channel.jpg "Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)")
AI Predicts Tumor-Killing Cells with High Accuracy
Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more
Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more
AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more
Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read moreMicrobiology
view channel
Integrated Solution Ushers New Era of Automated Tuberculosis Testing
Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
Sepsis affects up to 50 million people globally each year, with bacteraemia, formerly known as blood poisoning, being a major cause. In the United States alone, approximately two million individuals are... Read more
Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more
Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
Antimicrobial resistance (AMR) is a serious global public health concern that claims millions of lives every year. It primarily results from the inappropriate and excessive use of antibiotics, which reduces... Read morePathology
view channel
Groundbreaking CRISPR Screen Technology Rapidly Determines Disease Mechanism from Tissues
Thanks to over a decade of advancements in human genetics, scientists have compiled extensive lists of genetic variations linked to a wide array of human diseases. However, understanding how a gene contributes... Read more
New AI Tool Classifies Brain Tumors More Quickly and Accurately
Precision in diagnosing and categorizing tumors is essential for delivering effective treatment to patients. Currently, the gold standard for identifying various types of brain tumors involves DNA methylation-based... Read more
Technology
view channel
New Diagnostic System Achieves PCR Testing Accuracy
While PCR tests are the gold standard of accuracy for virology testing, they come with limitations such as complexity, the need for skilled lab operators, and longer result times. They also require complex... Read more
DNA Biosensor Enables Early Diagnosis of Cervical Cancer
Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community.... Read more
Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
Microfluidics, which are miniature devices that control the flow of liquids and facilitate chemical reactions, play a key role in disease detection from small samples of blood or other fluids.... Read more
Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
Home testing gained significant importance during the COVID-19 pandemic, yet the availability of rapid tests is limited, and most of them can only drive one liquid across the strip, leading to continued... Read moreIndustry
view channel
Danaher and Johns Hopkins University Collaborate to Improve Neurological Diagnosis
Unlike severe traumatic brain injury (TBI), mild TBI often does not show clear correlations with abnormalities detected through head computed tomography (CT) scans. Consequently, there is a pressing need... Read more
Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership
Beckman Coulter Diagnostics (Brea, CA, USA) and MeMed BV (Haifa, Israel) have expanded their host immune response diagnostics partnership. Beckman Coulter is now an authorized distributor of the MeMed... Read more_1.jpg "Image: Thermo Fisher will distribute Bio-Techne products across Europe (Photo courtesy of 123RF)")
